TransMedics Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. 

CEO
Waleed H. Hassanein
CEOWaleed H. Hassanein
Employees
898
Employees898
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
1998
Founded1998
Employees
898
Employees898

TMDX Key Statistics

Market cap
2.96B
Market cap2.96B
Price-Earnings ratio
21.38
Price-Earnings ratio21.38
Dividend yield
Dividend yield
Average volume
750.70K
Average volume750.70K
High today
$85.30
High today$85.30
Low today
$80.59
Low today$80.59
Open price
$82.62
Open price$82.62
Volume
314.42K
Volume314.42K
52 Week high
$156.00
52 Week high$156.00
52 Week low
$60.11
52 Week low$60.11

Stock Snapshot

The current TransMedics Group(TMDX) stock price is $85.50, with a market capitalization of 2.96B. The stock trades at a price-to-earnings (P/E) ratio of 21.38.

As of 2026-09-14, TransMedics Group(TMDX) stock has fluctuated between $80.59 and $85.30. The current price stands at $85.50, placing the stock +6.1% above today's low and +0.2% off the high.

TransMedics Group(TMDX) shares are trading with a volume of 314.42K, against a daily average of 750.7K.

In the last year, TransMedics Group(TMDX) shares hit a 52-week high of $156.00 and a 52-week low of $60.11.

In the last year, TransMedics Group(TMDX) shares hit a 52-week high of $156.00 and a 52-week low of $60.11.

TMDX News

TipRanks 4d
TransMedics Group Names New Chief Financial Officer

An update from TransMedics Group ( (TMDX) ) is now available. On September 10, 2026, TransMedics announced that veteran healthcare finance executive Fernando A...

Investing.com 4d
TransMedics names Fernando Araujo as CFO, reaffirms 2026 outlook - Investing.com

...

TransMedics names Fernando Araujo as CFO, reaffirms 2026 outlook - Investing.com
Nasdaq 4d
Transmedics Names Fernando Araujo CFO, Reiterates FY26 Outlook

(RTTNews) - On Thursday, TransMedics Group, Inc. (TMDX), a portable warm perfusion provider, announced that it has appointed Fernando Araujo as Chief Financial...

Transmedics Names Fernando Araujo CFO, Reiterates FY26 Outlook

Analyst ratings

67%

of 12 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.